Search Results
Slidesets
Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam | Daisuke Mizushima
Presented at:
APACC 2016
Slidesets
Ontwikkelingen HIV resistentie en eliminatie - Charles Boucher, MD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
Long acting (LA) drug delivery in TB treatment | Andrew Owen, BSS, MSC, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Mutations in the 3’-polypurine tract of HIV-1 point to a new integrase strand transfer inhibitor (INSTI) resistance mechanism in vivo- Jeroen van Kampen
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
B/F/TAF in treatment-naïve HIV-1 and HIV-1 RNA suppressed switch patients- Kirsten White, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Translational pharmacokinetic modelling & simulation of an experimental long-acting injectable formulation of bedaquiline- An Vermeulen, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Ricardo Diaz, MD - Dual Regimen – What Are the Resistance Considerations?
Presented at:
African HIV Clinical Forum 2022
Slidesets
Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MD
Presented at:
Salvador HIV Clinical Forum 2019
Abstracts
HIV drug resistance and distribution of genotypes among ART-naïve patients in Uzbekistan
Presented at:
European Workshop on Healthy Living with HIV 2019